Nice bit of media coverage today
...
ASX-listed telehealth stocks to look for in August 2021Summary
- With the COVID-19 pandemic driving increased demand for healthcare and avoiding physical contact, the use of telehealth or telemedicine has expanded rapidly.
- With customers acknowledging the benefits of telehealth, including convenience and accessibility, experts believe that the trend is here to stay, irrespective of vaccine rollout and the fight against the pandemic.
- The growing demand for telehealth services has seen companies report impressive financial performance.
- HeraMed, ResMed, Oneview Healthcare and CardieX are some of the ASX-listed leading players in the telehealth space.
CardieX Limited (ASX:CDX)
Global health technology company CardieX is focused on providing its services for the management of cardiovascular indications, hypertension, as well as other vascular health disorders.
On 26 July 2021, CardieX updated the market with its June 2021 quarter update highlighting strong sales growth. With a strong sales growth, the Company’s revenue increased 32% on a constant currency basis for the year-to-date on the comparative period in FY20.
The Company highlighted that the sales of the XCEL and Oscar 2 devices continue to perform very well in research, clinical trial, and specialist clinician markets.
MUST WATCH: What is Telehealth & How Does Telehealth Work?
Based on the solid growth, CardieX sees its internal sales target for FY22 to increase significantly over FY21 results, which the Company anticipates will provide a return to profitability for its ATCOR division by CY2022 end.
Moreover, Under the CONNEQT brand, the Company remains on track to roll out several new devices and digital products to the market over the upcoming twelve months.
Add to My Watchlist
What is My Watchlist?
